Read Content Only

Dana-Farber Brigham and Women's Cancer Center Banner

select font size Increase Font Size twelve pixels Increase Font Size fourteen pixels Increase Font Size sixteen pixels Email this link print page content

Diseases Treated


Cervical Cancer

Clinical trials for Cervical cancer

If you're interested in a cervical cancer clinical trial, please contact one of our Gyn Oncology Research Nurses:

Julie Lee, RN (617) 632-4975
Christin Whalen (617) 582-7738

Protocol 05-020: PTK787 Plus Docetaxel for Recurrent Mullerian Malignancies

This is a Phase II study to measure the effectiveness of oral PTK787, a drug that blocks angiogenesis, and docetaxel (taxotere), given weekly intravenously. Another aspect of this study is to test the effect of this drug combination on special MRI scans, called DC-MRI scans.

More cervical cancer clinical trials

Please continue to check this site for updates. New clinical trials for cervical cancer are added regularly.

Entering a Clinical Trial; Is it Right for You?

Gynecologic Cancer Treatment Center
Program Home
Our Services
Diseases Treated
     Cervical Cancer
     Endometrial Cancer
     Gestational Trophoblastic Disease / Molar Pregnancy
     Ovarian Cancer
     Primary Peritoneal Cancer
     Tubal Cancer
     Vaginal Cancer
     Vulvar Cancer
Patient Information
The Treatment Team
Clinical Trials
Research
Referring Physicians
Contact Information

This page was last modified on 07/15/08